Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Bioverativ Inc. (BIVV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/10/2018 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 0% stake in Bioverativ Inc. |
| 03/19/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/08/2018 |
4
| Protopapas Anna (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 1,056 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 23,006 options to buy
@ $52.08, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Posner Brian S (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 6,693 shares
@ $0
Disposed/sold 6,364 restricted stock units
@ $0
Disposed/sold 2,980 options to buy
@ $44.51, valued at
$132.6k
Disposed/sold 26,818 options to buy
@ $44.51, valued at
$1.2M
|
|
| 03/08/2018 |
4
| PAGLIA LOUIS J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Gifted 2,000 shares
@ $0
Disposed/sold 3,056 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 26,818 options to buy
@ $44.51, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Harris Timothy J.R. (EVP, R & D) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 839 shares
@ $0
Disposed/sold 11,271 restricted stock units
@ $0
Disposed/sold 40,909 restricted stock units
@ $0
Disposed/sold 34,556 options to buy
@ $56.34, valued at
$1.9M
Disposed/sold 33,759 options to buy
@ $56.34, valued at
$1.9M
|
|
| 03/08/2018 |
4
| Greene John (EVP, CFO and Treasurer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,951 shares
@ $0
Disposed/sold 14,230 restricted stock units
@ $0
Disposed/sold 42,727 restricted stock units
@ $0
Disposed/sold 113,230 options to buy
@ $44.51, valued at
$5M
Disposed/sold 56,615 options to buy
@ $44.51, valued at
$2.5M
|
|
| 03/08/2018 |
4
| Germano Geno J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 21,729 options to buy
@ $55.04, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 2,791 shares
@ $0
Disposed/sold 2,780 restricted stock units
@ $0
Disposed/sold 7,273 restricted stock units
@ $0
Disposed/sold 7,030 options to buy
@ $52.08, valued at
$366.1k
Disposed/sold 11,062 options to buy
@ $44.51, valued at
$492.4k
|
|
| 03/08/2018 |
4
| DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 30,600 shares
@ $0
Disposed/sold 7,489 restricted stock units
@ $0
Disposed/sold 31,818 restricted stock units
@ $0
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
|
|
| 03/08/2018 |
4
| DENNER ALEXANDER J (Director) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,001 shares
@ $0
Disposed/sold 1,165,000 shares
@ $0
Disposed/sold 5,455 restricted stock units
@ $0
Disposed/sold 26,818 options to buy
@ $44.51, valued at
$1.2M
|
|
| 03/08/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 185,094 shares
@ $0
Disposed/sold 136,364 restricted stock units
@ $0
Disposed/sold 48,678 restricted stock units
@ $0
Disposed/sold 48,230 options to buy
@ $7.82, valued at
$377.2k
Disposed/sold 387,366 options to buy
@ $44.51, valued at
$17.2M
Disposed/sold 193,683 options to buy
@ $44.51, valued at
$8.6M
|
|
| 03/08/2018 |
4
| Vivaldi Coelho Rogerio (EVP, Chief Global Therapeutics) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 5,758 shares
@ $0
Disposed/sold 14,230 restricted stock units
@ $0
Disposed/sold 42,727 restricted stock units
@ $0
Disposed/sold 113,230 options to buy
@ $44.51, valued at
$5M
Disposed/sold 56,615 options to buy
@ $44.51, valued at
$2.5M
|
|
| 03/08/2018 |
4
| Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 20,396 shares
@ $0
Disposed/sold 7,489 restricted stock units
@ $0
Disposed/sold 31,818 restricted stock units
@ $0
Disposed/sold 14,899 options to buy
@ $44.51, valued at
$663.2k
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
|
|
| 03/08/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Disposed/sold 22,952 shares
@ $0
Disposed/sold 7,489 restricted stock units
@ $0
Disposed/sold 31,818 restricted stock units
@ $0
Disposed/sold 14,899 options to buy
@ $44.51, valued at
$663.2k
Disposed/sold 29,797 options to buy
@ $44.51, valued at
$1.3M
Disposed/sold 59,595 options to buy
@ $44.51, valued at
$2.7M
|
|
| 03/08/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/08/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/08/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/08/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/08/2018 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 03/08/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 03/08/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/08/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/06/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for SandRidge Energy, BIOVERATIV INC, Ultra Clean, The Mosaic, Papa John's International, and Chegg — Fundamental Analysis, Key Performance Indications |
| 03/05/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 105 shares
@ $104.73, valued at
$11k
|
|
| 02/28/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/27/2018 |
SC 13G/A
| PRIMECAP MANAGEMENT CO reports a 7.1% stake in Bioverativ Inc. |
| 02/26/2018 |
4
| Duvall Diantha (Chief Accounting Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 168 shares
@ $104.3, valued at
$17.5k
|
|
| 02/26/2018 |
4
| Cox John (CEO) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 13,973 shares
@ $104.3, valued at
$1.5M
Paid exercise price by delivering 5,794 shares
@ $104.74, valued at
$606.9k
|
|
| 02/26/2018 |
4
| Celona Lucia (EVP, HR & Corp Commun. Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 1,235 shares
@ $104.3, valued at
$128.8k
Paid exercise price by delivering 389 shares
@ $104.74, valued at
$40.7k
|
|
| 02/26/2018 |
4
| DiFabio Andrea (EVP, Chief Legal Officer) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 2,011 shares
@ $104.3, valued at
$209.7k
Paid exercise price by delivering 917 shares
@ $104.74, valued at
$96k
|
|
| 02/26/2018 |
4
| Brudnick Richard (EVP, Business Development) has filed a Form 4 on Bioverativ Inc.|
Txns:
| Paid exercise price by delivering 1,419 shares
@ $104.3, valued at
$148k
Paid exercise price by delivering 924 shares
@ $104.74, valued at
$96.8k
|
|
| 02/23/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/23/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|